Annual Report

Overview

The report describes CCM Duopharma's 2017 transition into a PNB Group subsidiary following its demerger from CCMB. It reports consolidated turnover of 467,987 RM'000, alongside expansion in oncology, biologics and effervescent manufacturing capabilities. Sustainability highlights include Halal-certified pharmaceutical leadership, SHE policies and committees, 3R waste management, and a 29% reduction in total scheduled waste.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Extract
Fiscal year: 2017
Period: Ends 31 December 2017
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services